Pureims B.V. news

PureIMS will be present at the Drug Delivery to the Lungs Conference 2022 in Edinburgh. Please visit our stand (246) and have a chat.

We will be more than happy to tell you everything about our Cyclops™ single-use dry powder inhaler and hear all about your interesting projects too!

Furthermore, check out our posters on

OFF episodes are an unmet medical need with a great impact on the quality of life of Parkinson’s disease patients. Oral levodopa does not prevent the occurrence of OFF episodes, nor enables their fast resolve, mainly because of a highly variable and unreliable absorption through this route of administration. The pulmonary administration of levodopa results in faster and more reliable systemic absorption, which makes it a promising alternative for the rescue treatment

Roden — July 7, 2021 — Mycobacterium abscessus is a nontuberculous mycobacterium (NTM) that primarily causes severe pulmonary infections. The pathogen is also known as the ‘antibiotic nightmare’, due to its resistance to nearly all antibiotics. Following successful research into a potential treatment option, PureIMS, Radboudumc and Sever Pharma Solutions (until recently known as Disphar International) are now teaming u